Terms: = Brain cancer AND TRIM33, RFG7, 51592, ENSG00000197323, Q9UPN9, TF1G, FLJ32925, TIF1G, PTC7, TIFGAMMA, TIF1GAMMA
7 results:
1. Valproic Acid Inhibits Glioma and Its Mechanisms.
Yang ZY; Wang XH
J Healthc Eng; 2022; 2022():4985781. PubMed ID: 35251569
[TBL] [Abstract] [Full Text] [Related]
2. KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast cancer.
Yu B; Luo F; Sun B; Liu W; Shi Q; Cheng SY; Chen C; Chen G; Li Y; Feng H
Adv Sci (Weinh); 2021 Oct; 8(20):e2100014. PubMed ID: 34392614
[TBL] [Abstract] [Full Text] [Related]
3. NanoString technology distinguishes anti-TIF-1γ
Preusse C; Eede P; Heinzeling L; Freitag K; Koll R; Froehlich W; Schneider U; Allenbach Y; Benveniste O; Schänzer A; Goebel HH; Stenzel W; Radke J
Brain Pathol; 2021 May; 31(3):e12957. PubMed ID: 34043263
[TBL] [Abstract] [Full Text] [Related]
4. Regulation of β-catenin by IGFBP2 and its cytoplasmic actions in glioma.
Verma BK; Kondaiah P
J Neurooncol; 2020 Sep; 149(2):209-217. PubMed ID: 32803659
[TBL] [Abstract] [Full Text] [Related]
5.
Peluffo G; Subedee A; Harper NW; Kingston N; Jovanović B; Flores F; Stevens LE; Beca F; Trinh A; Chilamakuri CSR; Papachristou EK; Murphy K; Su Y; Marusyk A; D'Santos CS; Rueda OM; Beck AH; Caldas C; Carroll JS; Polyak K
Cancer Res; 2019 Aug; 79(16):4173-4183. PubMed ID: 31239270
[TBL] [Abstract] [Full Text] [Related]
6. Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features.
Deng MY; Sill M; Chiang J; Schittenhelm J; Ebinger M; Schuhmann MU; Monoranu CM; Milde T; Wittmann A; Hartmann C; Sommer C; Paulus W; Gärtner J; Brück W; Rüdiger T; Leipold A; Jaunmuktane Z; Brandner S; Giangaspero F; Nozza P; Mora J; Morales la Madrid A; Cruz Martinez O; Hansford JR; Pietsch T; Tietze A; Hernáiz-Driever P; Stoler I; Capper D; Korshunov A; Ellison DW; von Deimling A; Pfister SM; Sahm F; Jones DTW
Acta Neuropathol; 2018 Aug; 136(2):239-253. PubMed ID: 29766299
[TBL] [Abstract] [Full Text] [Related]
7. Tumour suppressor trim33 targets nuclear β-catenin degradation.
Xue J; Chen Y; Wu Y; Wang Z; Zhou A; Zhang S; Lin K; Aldape K; Majumder S; Lu Z; Huang S
Nat Commun; 2015 Feb; 6():6156. PubMed ID: 25639486
[TBL] [Abstract] [Full Text] [Related]
